Oct. 27, 2021—Bio-Rad Laboratories launched its CFX Opus 96 Dx and CFX Opus 384 Dx systems, real-time PCR detection systems that have been listed with the FDA for IVD testing and that meet the CE-IVD requirement for IVD use in Europe. Both instruments are also registered with regulatory bodies for IVD use in Singapore and Canada.
The open systems can multiplex up to five targets to provide efficient IVD assay development and testing and offer precise quantification, accurate thermal cycler performance, and desktop management and analysis software with integrated security features.